🔎 Trials Near Me

Home › T-Cell Lymphoma › Massachusetts › Boston

T-Cell Lymphoma clinical trials in Boston, MA

9 studies for T-Cell Lymphoma are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

RecruitingPhase 2
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04803201

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

RecruitingPhase 1
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05010005

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

RecruitingPhase 2
  • Dana-Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

RecruitingPhase 1/2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT04104776

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

RecruitingPhase 2
  • Dana Farber Cancer Institute, Boston
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT05313243

A Registry for People With T-cell Lymphoma

RecruitingObservational study
  • Massachusetts General Hospital (Data Collection Only), Boston
  • Dana Farber Cancer Institute (Data Collection Only), Boston
All ages · All sexes · Updated May 20, 2026 · NCT05978141

MB-105 in Patients With CD5 Positive T-cell Lymphoma

RecruitingPhase 2
  • Massachusetts General Hospital, Boston
Ages 18 and older · All sexes · Updated Oct 3, 2025 · NCT06534060

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • Dana-Farber Cancer Institute, Boston
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

T-Cell Lymphoma trials in other cities

Other studies in Boston

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.